Pablove Foundation Inc

Pablove's powered by pablove childhood cancer research grants program is dedicated to awarding $50,000 seed grants to promising, early-career investigators. These grants enable researchers to discover and apply novel approaches to understanding childhood cancer, share their findings widely, and secure greater funding for larger, more advanced research projects and programs.this strategy has been remarkably successful in laying the foundation for exceptional breakthroughs in both scientific and clinical knowledge. Pablove's dream is to ensure that no brilliant, promising scientist goes unfunded during the crucial early phase of research needed to advance discoveries from the lab bench to the patient bedside. Children everywhere are waiting for the innovative treatments and cures that this research can provide.in 2024, we awarded two powered by pablove seed grants, each providing $50,000 for one year of funding. We also continued funding for one powered by pablove grant focused on opsoclonus myoclonus syndrome (oms), which provided $100,000 over two years.pablove-funded research is conducted at prestigious institutions including johns hopkins university school of medicine, the hospital for sick children in toronto, the university of california, san francisco, and children's hospital los angeles, among others. Each project focuses on a different rare pediatric cancer, including opsoclonus myoclonus syndrome, pediatric brain tumors, osteosarcoma, and malignant peripheral nerve sheath tumors.pablove strongly believes in supporting these cutting-edge initiatives to uncover new pathways toward better treatments-and ultimately cures-for these challenging and often devastating pediatric cancers. Pediatric cancer research remains an underserved field, and we are committed to doing our part to make a difference. Continued investment is essential to discover more effective treatments and reduce side effects, protecting the futures of these precious children.